EU hits France's Sanofi with flu vaccine antitrust probe
The investigation centers on how the firm marketed an enhanced flu vaccine, offered under the brand name Efluelda and designed to provide greater protection for people over 60.
The investigation centers on how the firm marketed an enhanced flu vaccine, offered under the brand name Efluelda and designed to provide greater protection for people over 60.
